These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33963972)

  • 41. Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization.
    Rösen-Wolff A; Soldan W; Heyne K; Bickhardt J; Gahr M; Roesler J
    Ann Hematol; 2001 Feb; 80(2):113-5. PubMed ID: 11261321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB.
    Wolach B; Scharf Y; Gavrieli R; de Boer M; Roos D
    Blood; 2005 Jan; 105(1):61-6. PubMed ID: 15308575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation.
    Lewis EM; Singla M; Sergeant S; Koty PP; McPhail LC
    Clin Immunol; 2008 Nov; 129(2):372-80. PubMed ID: 18774749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox).
    de Boer M; de Klein A; Hossle JP; Seger R; Corbeel L; Weening RS; Roos D
    Am J Hum Genet; 1992 Nov; 51(5):1127-35. PubMed ID: 1415254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India.
    Rawat A; Singh S; Suri D; Gupta A; Saikia B; Minz RW; Sehgal S; Vaiphei K; Kamae C; Honma K; Nakagawa N; Imai K; Nonoyama S; Oshima K; Mitsuiki N; Ohara O; Chan KW; Lau YL
    J Clin Immunol; 2014 Jan; 34(1):58-67. PubMed ID: 24276928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discoid lupus erythematosus and carrier status of X-linked chronic granulomatous disease.
    Lindskov R; Munkvad JM; Valerius NH
    Dermatologica; 1983; 167(5):231-3. PubMed ID: 6653847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discoid lupus erythematosus in an X-linked cytochrome-positive carrier of chronic granulomatous disease.
    Yeaman GR; Froebel K; Galea G; Ormerod A; Urbaniak SJ
    Br J Dermatol; 1992 Jan; 126(1):60-5. PubMed ID: 1536763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Copy number variations due to large genomic deletion in X-linked chronic granulomatous disease.
    Arai T; Oh-ishi T; Yamamoto H; Nunoi H; Kamizono J; Uehara M; Kubota T; Sakurai T; Kizaki T; Ohno H
    PLoS One; 2012; 7(2):e27782. PubMed ID: 22383943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation.
    Anderson-Cohen M; Holland SM; Kuhns DB; Fleisher TA; Ding L; Brenner S; Malech HL; Roesler J
    Clin Immunol; 2003 Dec; 109(3):308-17. PubMed ID: 14697745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic granulomatous disease. Diagnosis by the dihydrorhodamine assay.
    Sanabria D; Giménez V; Martínez de Cuéllar C; Carpinelli M; Benegas S; Insaurralde S
    Rev Chil Pediatr; 2020 Feb; 91(1):19-26. PubMed ID: 32730409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease.
    Stasia MJ; Bordigoni P; Floret D; Brion JP; Bost-Bru C; Michel G; Gatel P; Durant-Vital D; Voelckel MA; Li XJ; Guillot M; Maquet E; Martel C; Morel F
    Hum Genet; 2005 Jan; 116(1-2):72-82. PubMed ID: 15538631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical, Immunological, and Molecular Profile of Chronic Granulomatous Disease: A Multi-Centric Study of 236 Patients From India.
    Rawat A; Vignesh P; Sudhakar M; Sharma M; Suri D; Jindal A; Gupta A; Shandilya JK; Loganathan SK; Kaur G; Chawla S; Patra PK; Khadwal A; Saikia B; Minz RW; Aggarwal V; Taur P; Pandrowala A; Gowri V; Desai M; Kulkarni M; Hule G; Bargir U; Kambli P; Madkaikar M; Bhattad S; Ginigeri C; Kumar H; Jayaram A; Munirathnam D; Sivasankaran M; Raj R; Uppuluri R; Na F; George B; Lashkari HP; Kalra M; Sachdeva A; Seth S; Sabui T; Gupta A; van Leeuwen K; de Boer M; Chan KW; Imai K; Ohara O; Nonoyama S; Lau YL; Singh S
    Front Immunol; 2021; 12():625320. PubMed ID: 33717137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Late Onset of Chronic Granulomatous Disease Revealed by Paecilomyces lilacinus Cutaneous Infection.
    Lemaigre C; Suarez F; Martellosio JP; Barbarin C; Brunet K; Chomel JC; Hainaut E; Rammaert B; Roblot F; Torregrosa-Diaz JM
    J Clin Immunol; 2022 Jan; 42(1):60-63. PubMed ID: 34596815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece.
    Raptaki M; Varela I; Spanou K; Tzanoudaki M; Tantou S; Liatsis M; Constantinidou N; Bakoula C; Roos D; Kanariou M
    J Clin Immunol; 2013 Nov; 33(8):1302-9. PubMed ID: 24081483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease.
    Li F; Linton GF; Sekhsaria S; Whiting-Theobald N; Katkin JP; Gallin JI; Malech HL
    Blood; 1994 Jul; 84(1):53-8. PubMed ID: 7517218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammatory manifestations in chronic granulomatous disease (CGD).
    Rosenzweig SD
    J Clin Immunol; 2008 May; 28 Suppl 1():S67-72. PubMed ID: 18193341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations of chronic granulomatous disease in Turkish families.
    Köker MY; Sanal O; De Boer M; Tezcan I; Metin A; Ersoy F; Roos D
    Eur J Clin Invest; 2007 Jul; 37(7):589-95. PubMed ID: 17576211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease.
    Fattahi F; Badalzadeh M; Sedighipour L; Movahedi M; Fazlollahi MR; Mansouri SD; Khotaei GT; Bemanian MH; Behmanesh F; Hamidieh AA; Bazargan N; Mamishi S; Zandieh F; Chavoshzadeh Z; Mohammadzadeh I; Mahdaviani SA; Tabatabaei SA; Kalantari N; Tajik S; Maddah M; Pourpak Z; Moin M
    J Clin Immunol; 2011 Oct; 31(5):792-801. PubMed ID: 21789723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic analysis of CYBB gene in 26 korean families with X-linked chronic granulomatous disease.
    Ko SH; Rhim JW; Shin KS; Hahn YS; Lee SY; Kim JG
    Immunol Invest; 2014; 43(6):585-94. PubMed ID: 24999735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.